Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Peripherally restricted cannabinoid type 1 receptor (CB1R) antagonist, AM6545, potentiates stress-induced hypothalamic-pituitary-adrenal axis activation via a non-CB1R mechanism. Endocrine 2021 Apr;72(1):297-300

Date

11/21/2020

Pubmed ID

33216305

Pubmed Central ID

PMC8528513

DOI

10.1007/s12020-020-02549-1

Scopus ID

2-s2.0-85096389716 (requires institutional sign-in at Scopus site)   3 Citations

Author List

Roberts CJ, Hillard CJ

Authors

Cecilia J. Hillard PhD Professor in the Pharmacology and Toxicology department at Medical College of Wisconsin
Christopher J. Roberts PhD, MD Associate Professor in the Anesthesiology department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Animals
Cannabinoid Receptor Antagonists
Female
Hypothalamo-Hypophyseal System
Male
Mice
Mice, Inbred ICR
Morpholines
Pituitary-Adrenal System
Pyrazoles
Receptor, Cannabinoid, CB1